Nomura Holdings’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-53,444
| Closed | -$474K | – | 980 |
|
|
2022
Q4 | $474K | Buy |
53,444
+16,500
| +45% | +$146K | ﹤0.01% | 598 |
|
|
2022
Q3 | $452K | Hold |
36,944
| – | – | ﹤0.01% | 709 |
|
|
2022
Q2 | $465K | Buy |
36,944
+17,444
| +89% | +$220K | ﹤0.01% | 768 |
|
|
2022
Q1 | $394K | Buy |
19,500
+8,989
| +86% | +$182K | ﹤0.01% | 942 |
|
|
2021
Q4 | $279K | Buy |
+10,511
| New | +$279K | ﹤0.01% | 1219 |
|
|
2021
Q3 | – | Sell |
-6,250
| Closed | -$355K | – | 1597 |
|
|
2021
Q2 | $355K | Sell |
6,250
-1,000
| -14% | -$56.8K | ﹤0.01% | 1151 |
|
|
2021
Q1 | $304K | Buy |
+7,250
| New | +$304K | ﹤0.01% | 1123 |
|